Patent US5079151A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5079151A Expired / Lapsed US ⏱️ 0.0 years remaining

Production of branched RNA-linked multi-copy single-stranded DNA using permeabilized cells

Assignee: Rutgers Health
•
Filing: 1989-02-24
•
Granted: 1992-01-07
•
Expires: 2009-02-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract msDNA is a peculiar molecule consisting of a branched RNA linked to single-stranded DNA via a 2', 5' phosphodiester bond. A cell-free system, utilizing cells permeablized with phenethyl, alcohol, was established to study the synthesis of msDNA in Myxococcus xanthus. Permeablized cell labeled with [α- 32 P]dCTP in the presence of ddGTP, ddATP, or ddTTP, produce a band that migrates at the same position as the full-sized msDNA in an acrylamide gel. However, when this band is treated with ribonuclease A prior to gel electrophoresis, it resulted in many bands of different sizes. This indicates that during the labeling, intermediates are produced in which single-stranded DNAs of various lengths are associated with a compensatory length of RNA such that the total length for each intermediate is identical. These results provide evidence for the previously proposed model in which msDNA is synthesized by reverse transcriptase using a folded RNA precursor as a primer as well as a template. Furthermore, it was found that there is a precise coupling mechanism of reverse transcriptase and ribonuclease H.

Inventors

  • 👤 Bert C. Lampson
  • 👤 Masayori Inouye
  • 👤 Sumiko Inouye

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 05:33
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/10; C12P; C12P19/00; C12P19/26; C12P19/28; C12P19/30; C12P19/34; Y; Y10; Y10S; Y10S435/00; Y10S435/8215; Y10S435/822

Claims Analysis

Total Claims: 18
Claim 1
Independent Claim 64 words
An in vitro method of synthesis for preparing a branched RNA-linked multi-copy single-stranded DNA (msDNA), having a 2',5'-phosphodiester linkage between the 5' end of the DNA and the branched RNA, comprising treating prokaryotic cells with a membrane-permeabilizing agent which renders the cells permeable to nucleoside triphosphates, incubating the permeabilized cells in a reaction mixture comprising substrates required for msDNA synthesis, and isolating the msDNA.
Claim 2
Dependent Claim 64 words
An in vitro method of synthesis for preparing a branched RNA-linked multi-copy single-stranded DNA (msDNA), having a 2',5'-phosphodiester linkage between the 5' end of the DNA and the branched RNA, comprising treating prokaryotic cells with a membrane-permeabilizing agent which renders the cells permeable to nucleoside triphosphates, incubating the permeabilized cells in a reaction mixture comprising substrates required for msDNA synthesis, and isolating the msDNA.
Claim 3
Dependent Claim 19 words
The process of claim 1 wherein the permeabilized cells are rendered non-viable by the treatment with the membrane-permeabilizing agent.
Claim 4
Dependent Claim 20 words
The method of claim 1 in which the reaction mixture comprises ATP, GTP, UTP, CTP, dATP, dGTP, dTTP and dCTP.
Claim 5
Dependent Claim 13 words
The method of claim 1 in which the prokaryotic cell is Myxococcus xanthus.
Claim 6
Dependent Claim 18 words
The process of claim 1 wherein the procaryotic permeabilized cell retains synthesis ability for RNA, DNA and protein.
Claim 7
Dependent Claim 25 words
The process of claim 1 wherein the membrane permeabilizing agent is an organic solvent selected from the group consisting of toluene and phenyl ethyl alcohol.
Claim 8
Dependent Claim 16 words
The process of claim 1 wherein the reaction mixture contains endogenous TTP, UTP, CTP and GTP.
Claim 9
Dependent Claim 21 words
The process of claim 7 which comprises the step of adding to the reaction mixture exogenous dTTP, dATP, dCTP and dGTP.
Claim 10
Dependent Claim 10 words
The process of claim 8 which comprises adding exogenous ATP.
Claim 11
Dependent Claim 22 words
The process of claim 9 wherein the added ATP is in excess of any one of the dTTP, dATP, dCTP and dGTP.
Claim 12
Dependent Claim 114 words
The process of claim 7 of synthesizing the msDNA which comprises the steps of synthesizing primary RNA molecule which folds into a stable stem-and-loop structure, thereby forming a secondary RNA structure, in which secondary RNA structure an rG residue is positioned to be accessible for priming DNA synthesis, priming and after formation of a branched linkage between the 2'-OH of rG and the 5' end of the first deoxyribonucleotide, synthesizing the DNA strand along the RNA template by reverse transcriptase, processing the RNA template by its RNase H mediated digestion, terminating the reverse transcriptase reaction by dissociation of the RT-RNase H enzyme complex from the template, completing the msDNA synthesis and isolating the msDNA.
Claim 13
Dependent Claim 32 words
The process of claim 11 wherein the processing of the RNA includes the removal of its first 75 bases from the 5' end and the last 70 bases from the 3' end.
Claim 14
Dependent Claim 36 words
The process of claim 11 wherein while synthesis of the DNA strand continues along the RNA template by reverse transcriptase, removal of the RNA template within the growing DNA-RNA duplex by the RNase activity takes place.
Claim 15
Dependent Claim 12 words
The process of claim 11 wherein the procaryotic cells are myxobacterium cells.
Claim 16
Dependent Claim 11 words
The process of claim 14 wherein the cells are Myxococcus xanthus.
Claim 17
Dependent Claim 24 words
The process of claim 11 wherein the primary RNA molecule contains two inverted repeat sequences which contribute to the folding into the stable-and-loop structure.
Claim 18
Dependent Claim 29 words
The process of claim 16 wherein the inverted repeats are positioned immediately upstream of the branched G residue and immediately upstream of the start of the DNA coding region.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1995-01-06 1995-07-08 1996-01-07 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1999-01-06 1999-07-08 2000-01-07 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2003-01-06 2003-07-08 2004-01-07 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag